CoChat

Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication

Hanaoka, Noboru, Uedo, Noriya, Shiotani, Akiko, Inoue, Takuya, Takeuchi, Yoji, Higashino, Koji, Ishihara, Ryu, Iishi, Hiroyasu, Haruma, Ken, Tatsuta, Masaharu · 2010 · Journal of Gastroenterology and Hepatology
Cited by 54

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background and Aims: Although Helicobacter pylori eradication decreases the incidence of metachronous gastric cancer after endoscopic treatment for early gastric cancer (EGC), metachronous cancer still develops after successful eradication, particularly in patients with severe corpus gastritis. We investigated whether the extent of atrophic fundic gastritis diagnosed by autofluorescence imaging (AFI) videoendoscopy is predictive of development of metachronous gastric cancer after H. pylori eradication in patients treated with endoscopic submucosal dissection (ESD) for EGC. Patients and Methods: A total of 82 patients who underwent ESD for EGC from 2003 to 2006, who received eradication therapy participated in this study. The extent of chronic atrophic fundic gastritis was evaluated by AFI and categorized into closed and open type. The main outcome was the incidence of metachronous gastric cancer detected by annual surveillance endoscopy. Results: During a median observation period of 55 months, metachronous gastric cancer developed in 12 of 82 patients (14.6%). Multivariate Cox's proportional hazard analysis revealed that open‐type, atrophic fundic gastritis diagnosed by AFI was significantly associated with development of metachronous gastric cancer (hazard ratio: 4.88, 95% confidence interval [CI]: 1.32–18.2, P = 0.018) after adjustment for age, sex, histological intestinal metaplasia, serum pepsinogen level, and H. pylori status. Conclusions: Metachronous EGC developed after successful H. pylori eradication, and extensive atrophic fundic gastritis diagnosed by AFI was a significant predictor, thus it could identify patients undergoing ESD for EGC who still required intensive surveillance after eradication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1746.2010.06442.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 54

Metadata

Authors
Hanaoka, N., Uedo, N., Shiotani, A., Inoue, T., Takeuchi, Y., Higashino, K., Ishihara, R., Iishi, H., Haruma, K., & Tatsuta, M.
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2010-11-23
Volume
25
Issue
12
Pages
1844-1849
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W1507665716
Cited by
54
References
1
FWCI
3.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication. https://app.cochat.ai/papers/10.1111/j.1440-1746.2010.06442.x
The paper
Hanaoka, N., Uedo, N., Shiotani, A., Inoue, T., Takeuchi, Y., Higashino, K., Ishihara, R., Iishi, H., Haruma, K., & Tatsuta, M. (2010). Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.2010.06442.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.